Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Can antivirulence drugs stop infections without causing resistance?

11.10.2011
Antivirulence drugs disarm pathogens rather than kill them, and although they could be effective in theory, antivirulence drugs have never been tested in humans. A new study to be published in the online journal mBio® on Tuesday, October 18 reveals these drugs have the potential to fight infection while avoiding the pitfalls of drug resistance.

Traditional antibiotics aim to kill or stop the growth of pathogens, but antivirulence drugs prevent disease by neutralizing virulence factors, the specific proteins or toxins that a pathogen uses to establish an infection.

Scientists have long thought such a strategy could prevent pathogens from developing drug resistance, since antivirulence drugs don't kill the pathogens that are susceptible and leave a wide opening for the few resistant organisms that may be left. Thus, in theory, antivirulence drugs don't offer much benefit to the pathogens that get around the drug. However, these ideas have never been tested.

The study coming out this week provides evidence that antivirulence drugs have the potential to suppress resistance if they are applied in the right way. Brett Mellbye and Martin Schuster from Oregon State University carried out laboratory simulations to determine the effect antivirulence drug-resistant strains could have on therapy. They found that in pathogens that rely on cell-to-cell communication and cooperation, resistant strains will not overtake sensitive strains, allowing antivirulence therapies that target social interactions to work even when resistance arises.

"It's a very important demonstration of the principle that social effects can slow or even halt the spread of resistance to antivirulence drugs," says Sam Brown, of Edinburgh University, Invited Editor on the study. "Their results align with our understanding of social evolution."

Mellbye and Schuster created a microcosm that simulates an infection, says Brown, and they used bacteria that employ quorum sensing, a form of communication that enables the bacteria to time their attack for greatest effect. Quorum sensing is an important target for antivirulence drugs because many bacterial pathogens, including the lung pathogen Pseudomonas aeruginosa, employ quorum sensing to control the manufacture of their virulence factors.

To circumvent the problem of creating a strain that is resistant to an antivirulence drug, Brown says, the authors used surrogates. "It's kind of a role-playing exercise," to test their ideas, he says. "They used bacteria that behave as we expect drug-resistant bacteria might behave." "Sensitive" mimics are bacteria that lack the ability to communicate and cooperate. "Resistant" mimics are actually run-of-the-mill bacteria that retain the ability to "talk" amongst themselves.

The researchers pitted resistant mimics against sensitive mimics to test whether resistant strains can proliferate in an infection. The results showed that sensitive mimics cheat to get ahead: they exploit the resources that the resistant bacteria provide through quorum sensing. This delays the growth of all the bacteria, suggesting that resistance to an antivirulence drug that targets quorum sensing would not spread. The authors say this highlights the potential of antivirulence strategies that target cooperative behaviors and shared virulence factors.

Brown is optimistic but circumspect about the findings. "These results could very well stand, but in the the real world resistance could still emerge and we need to be cautious."

"I think these drugs are promising, even if we do anticipate resistance, because they can slow the rate of resistance evolution, much slower than the rate of resistance evolution to traditional antibiotics," says Brown.

mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://www.mbio.asm.org

Jim Sliwa | EurekAlert!
Further information:
http://www.asmusa.org
http://www.mbio.asm.org

More articles from Health and Medicine:

nachricht 'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers
16.02.2018 | National University of Science and Technology MISIS

nachricht New process allows tailor-made malaria research
16.02.2018 | Eberhard Karls Universität Tübingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Erste integrierte Schaltkreise (IC) aus Plastik

Erstmals ist es einem Forscherteam am Max-Planck-Institut (MPI) für Polymerforschung in Mainz gelungen, einen integrierten Schaltkreis (IC) aus einer monomolekularen Schicht eines Halbleiterpolymers herzustellen. Dies erfolgte in einem sogenannten Bottom-Up-Ansatz durch einen selbstanordnenden Aufbau.

In diesem selbstanordnenden Aufbauprozess ordnen sich die Halbleiterpolymere als geordnete monomolekulare Schicht in einem Transistor an. Transistoren sind...

Im Focus: Quantenbits per Licht übertragen

Physiker aus Princeton, Konstanz und Maryland koppeln Quantenbits und Licht

Der Quantencomputer rückt näher: Neue Forschungsergebnisse zeigen das Potenzial von Licht als Medium, um Informationen zwischen sogenannten Quantenbits...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Das VLT der ESO arbeitet erstmals wie ein 16-Meter-Teleskop

Erstes Licht für das ESPRESSO-Instrument mit allen vier Hauptteleskopen

Das ESPRESSO-Instrument am Very Large Telescope der ESO in Chile hat zum ersten Mal das kombinierte Licht aller vier 8,2-Meter-Hauptteleskope nutzbar gemacht....

Im Focus: Neuer Quantenspeicher behält Information über Stunden

Information in einem Quantensystem abzuspeichern ist schwer, sie geht meist rasch verloren. An der TU Wien erzielte man nun ultralange Speicherzeiten mit winzigen Diamanten.

Mit Quantenteilchen kann man Information speichern und manipulieren – das ist die Basis für viele vielversprechende Technologien, vom hochsensiblen...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

VideoLinks
Industrie & Wirtschaft
Veranstaltungen

Auf der grünen Welle in die Zukunft des Mobilfunks

16.02.2018 | Veranstaltungen

Smart City: Interdisziplinäre Konferenz zu Solarenergie und Architektur

15.02.2018 | Veranstaltungen

Forschung für fruchtbare Böden / BonaRes-Konferenz 2018 versammelt internationale Bodenforscher

15.02.2018 | Veranstaltungen

VideoLinks
Wissenschaft & Forschung
Weitere VideoLinks im Überblick >>>
 
Aktuelle Beiträge

Erste integrierte Schaltkreise (IC) aus Plastik

17.02.2018 | Energie und Elektrotechnik

Stammbaum der Tagfalter erstmalig umfassend neu aufgestellt

16.02.2018 | Biowissenschaften Chemie

Neue Strategien zur Behandlung chronischer Nierenleiden kommen aus der Tierwelt

16.02.2018 | Biowissenschaften Chemie

Weitere B2B-VideoLinks
IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics